Relationship between serum ferritin and inflammatory biomarkers with insulin resistance in a Persian population with type 2 diabetes and healthy people

References

• Brunner EJ, Kivimäki M, Witte DR, Lawlor DA, Davey Smith G, Cooper JA, Miller M, Lowe GD, Rumley A, Casas JP, 2008. Inflammation, insulin resistance, and diabetes—Mendelian randomization using CRP haplotypes points upstream. PLoS Med 5:e155.
   PubMed Web of Science ®Google Scholar
• Campos SP, Baumann H. 1992. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 12:1789–1797.
   PubMed Web of Science ®Google Scholar
• Chen X, Scholl TO, Stein TP. 2006. Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women: the Camden study. Diabetes Care 29:1077-1082.
   PubMed Web of Science ®Google Scholar
• Cheng YC, Kuo WW, Wu CH, Shu WT, Kuo CH, Hwang JM, Hsu HH, Chen LM, Huang CY, Lee SD. 2008. Iron status and cardiovascular risk factors in patients with haemodialysis versus patients with ischaemic heart disease. Nephrology (Carlton) 14:65–69.
   Google Scholar
• Fahmy M, Young SP. 1993. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem J 296(Pt 1):175–181.
   PubMedGoogle Scholar
• Fernández-Real JM, Ricart-Engel W, Arroyo E, Balançá R, Casamitjana-Abella R, Cabrero D, Fernández-Castañer M, Soler J 1998. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21:62–68.
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Lopez-Bermejo A, Ricart W. 2002. Cross-talk between iron metabolism and diabetes. Diabetes 51:2348–2354.
   PubMed Web of Science ®Google Scholar
• Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, Bingham S, Khaw KT, Wareham NJ 2007. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 50:949–956.
   PubMed Web of Science ®Google Scholar
• Fumeron F, Péan F, Driss F, Balkau B, Tichet J, Marre M, Grandchamp B 2006. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes Care 29:2090–2094.
   PubMed Web of Science ®Google Scholar
• Gallagher ML. 2008. The nutrients and their metabolism. Krauses food and nutrition therapy. Philadelphia: Saunders-Elsevier. pp: 114–120.
   Google Scholar
• Gomez JM, Vila R, Catalina P, Soler J, Badimon L, Sahun M. 2008. The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives. Glycoconjugate J 25:573–579.
   PubMed Web of Science ®Google Scholar
• Hernandez C, Lecube A, Carrera A, Simo R. 2005. Soluble transferrin receptors and ferritin in type 2 diabetic patients. Diabet Med 22:97–101.
   PubMed Web of Science ®Google Scholar
• Jehn M, Clark JM, Guallar E. 2004. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 27:2422–2428.
   PubMed Web of Science ®Google Scholar
• Jiang L, Wang A, Molyneaux LM, Constantino MI, Yue DK. 2008. The long-term impact of ferritin level on treatment and complications of type 2 diabetes. Diabetes Obes Metab 10:519–522.
   PubMed Web of Science ®Google Scholar
• Lao TT, Ho LF. 2004. Impact of iron deficiency anemia on prevalence of gestational diabetes mellitus. Diabetes Care 27:650–656.
   PubMed Web of Science ®Google Scholar
• Mburu AS, Thurnham DI, Mwaniki DL, Muniu EM, Alumasa F, de Wagt A. 2008. The influence and benefits of controlling for inflammation on plasma ferritin and hemoglobin responses following a multi-micronutrient supplement in apparently healthy, HIV+ Kenyan adults. J Nutr 138:613–619.
   PubMed Web of Science ®Google Scholar
• Mlinar B, Marc J, Janez A, Pfeifer M. 2007. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 375:20–35.
   PubMed Web of Science ®Google Scholar
• Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Sacce L, Ferrannini E. 2006. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 55:1133–1140.
   PubMed Web of Science ®Google Scholar
• Orino K, Watanabe K. 2008. Molecular, physiological and clinical aspects of the iron storage protein ferritin. Vet J 178:191–201.
   PubMed Web of Science ®Google Scholar
• Rambod M, Kovesdy CP, Kalantar-Zadeh K. 2008. Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation. Clin J Am Soc Nephrol 3:1691–1701.
   PubMed Web of Science ®Google Scholar
• Report of a WHO Expert Committee. 1995. Physical status: the use and interpretation of anthropometry. Technical Report Series No. 854. Geneva.
   Google Scholar
• Schulze MB, Hoffmann K, Manson JE, Willett WC, Meigs JB, Weikert C, Heidemann C, Colditz GA, Hu FB. 2005. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 82:675–684; quiz 714–715.
   PubMed Web of Science ®Google Scholar
• Shah A, Mehta N, Reilly MP. 2008. Adipose inflammation, insulin resistance, and cardiovascular disease. J Parenter Enteral Nutr 32:638–644.
   PubMed Web of Science ®Google Scholar
• Sharifi F, Nasab NM, Zadeh HJ. 2008. Elevated serum ferritin concentrations in prediabetic subjects. Diab Vasc Dis Res 5:15–18.
   PubMed Web of Science ®Google Scholar
• Shi Z, Hu X, Yuan B, Pan X, Meyer HE, Holmboe-Ottesen G. 2006. Association between serum ferritin, hemoglobin, iron intake, and diabetes in adults in Jiangsu, China. Diabetes Care 29:1878–1883.
   PubMed Web of Science ®Google Scholar
• Smirnov IM, Bailey K, Flowers CH, Garrigues NW, Wesselius LJ. 1999. Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity. Am J Physiol 277:L257–L263.
   PubMedGoogle Scholar
• Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H, Ye X, Qi Q, Wang J, Pan A, 2008. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab 93:4690–4696.
   PubMed Web of Science ®Google Scholar
• Tuomainen TP, Nyyssönen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA, Salonen JT. 1997. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 20:426–428.
   PubMed Web of Science ®Google Scholar
• Van Campenhout A, Van Campenhout C, Lagrou AR, Abrams P, Moorkens G, Van Gaal L, Manuel-Y-Keenoy B. 2006. Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status. Diabetes Metab Res Rev 22:444–454.
   PubMed Web of Science ®Google Scholar
• Wrede CE, Buettner R, Bollheimer LC, Scholmerich J, Palitzsch KD, Hellerbrand C. 2006. Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol 154:333–340.
   PubMed Web of Science ®Google Scholar
• Yuan G, Zhou L, Tang J, Yang Y, Gu W, Li F, Hong J, Gu Y, Li X, Ning G, 2006. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Res Clin Pract 72:244–250.
   PubMed Web of Science ®Google Scholar